13F HOLDINGS REPORT
ARCH Venture Management, LLC
Quarter ended Q4 2023 · Filed November 14, 2023 · Accession 0001012975-23-000461
Total Value
$154.0M
Positions
7
Other Managers
0
Confidential Omitted
No
Holdings (7)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | EQRX, INC. | 26886C107 | 36,335,375 | $80.7M | 52.39% |
| 2 | VERVE THERAPEUTICS, INC. | 92539P101 | 2,008,809 | $26.6M | 17.30% |
| 3 | ERASCA, INC. | ERAS | 11,055,554 | $21.8M | 14.15% |
| 4 | DENALI THERAPEUTICS, INC. | DNLI | 693,749 | $14.3M | 9.30% |
| 5 | GOSSAMER BIO, INC. | GOSS | 8,055,916 | $6.7M | 4.36% |
| 6 | UNITY BIOTECHNOLOGY, INC. | UNTCW | 1,004,817 | $2.4M | 1.57% |
| 7 | SINGULAR GENOMICS SYSTEMS, INC. | 82933R100 | 3,798,926 | $1.4M | 0.94% |